An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults
Abroad (travel likely)RecruitingPHASE3
Conditions
Chikungunya Virus
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
WRAIR-AFRIMS Philippines, Cebu (WRAIR-APC), Cebu City, Cebu, Philippines
Contact: Study coordinator (Bavarian Nordic Investigative Site)Kamphaeng Phet Provincial Hospital, Kamphaeng Phet, Changwat Kamphaeng Phet, Thailand
Contact: Study coordinator (Bavarian Nordic Investigative Site)Songklanagarind hospital, Prince of Songkla University (PSU), Hat Yai, Changwat Songkhla, Thailand
Contact: Study coordinator (Bavarian Nordic Investigative Site)
Study leads
Patrick Ajiboye, MD
Study Director
Bavarian Nordic A/S